Your browser doesn't support javascript.
loading
Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine.
Quiambao, Beatriz; Peyrani, Paula; Li, Ping; Cutler, Mark W; Van Der Wielen, Marie; Perez, John L; Webber, Chris.
Affiliation
  • Quiambao B; Clinical Research Division, Research Institute for Tropical Medicine , Alabang, Muntinlupa City, Philippines.
  • Peyrani P; Pfizer Vaccine Clinical Research and Development, Pfizer Inc , Collegeville, PA, USA.
  • Li P; Pfizer Vaccine Clinical Research and Development, Pfizer Inc , Collegeville, PA, USA.
  • Cutler MW; Pfizer Vaccine Research and Development, Pfizer Inc , Pearl River, NY, USA.
  • Van Der Wielen M; Vaccines R & D, GlaxoSmithKline , Wavre, Belgium.
  • Perez JL; Pfizer Vaccine Clinical Research and Development, Pfizer Inc , Collegeville, PA, USA.
  • Webber C; Pfizer Vaccine Clinical Research and Development, Pfizer Inc , Hurley, UK.
Hum Vaccin Immunother ; 16(6): 1272-1279, 2020 06 02.
Article in En | MEDLINE | ID: mdl-32401600
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Meningococcal Vaccines / Meningococcal Infections Limits: Humans Language: En Journal: Hum Vaccin Immunother Year: 2020 Document type: Article Affiliation country: Filipinas
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Meningococcal Vaccines / Meningococcal Infections Limits: Humans Language: En Journal: Hum Vaccin Immunother Year: 2020 Document type: Article Affiliation country: Filipinas